product summary
Loading...
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human CD160 Fc Chimera Protein, CF
catalog :
11575-CD-050
quantity :
50 ug
price :
443 USD
more info or order :
image
image 1 :

product information
brand :
R&D Systems
master code :
11575-CD
SKU :
11575-CD-050
product name :
Recombinant Human CD160 Fc Chimera Protein, CF
unit size :
50 ug
seo description :
The Recombinant Human CD160 Fc Chimera Protein, CF has been validated for the following applications: Bioactivity.
target :
CD160
category :
Proteins and Enzymes
buffer :
Lyophilized from a 0.2 ╡m filtered solution in PBS with Trehalose.
conjugate :
Unconjugated
dilution :
Bioactivity
species :
Human
observed molecular weight :
39-59 kDa, under reducing conditions
theoretical molecular weight :
41 kDa
applications :
Bioactivity
USD :
443 USD
alt names :
BY55, BY55FLJ46513, CD160, CD160 antigenimmunoglobulin superfamily member, CD160 molecule, Natural killer cell receptor BY55, NK1, NK28
storage :
Store the unopened product at -20 to -70 ░C. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Do not use past expiration date.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
browse more products
- Recombinant Human IL-21R Fc Chimera Avi-tag Protein, CF | AVI991-050
- Recombinant Human CD44v6 Fc Chimera Avi-tag Protein, CF | AVI11175-050
- Recombinant Human CD6 Fc Chimera Avi-tag Protein, CF | AVI11123-050
- Recombinant Human TGF-beta 3, Animal-Free Protein | Qk054-0500
- Recombinant Human IL-10 R beta Fc Chimera Avi Protein, CF | AVI11460-050
questions and comments